INMED PHARMACEUTICALS INC's ticker is INM and the CUSIP is 457637502. A total of 19 filers reported holding INMED PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Empery Asset Management, LP | 61,741 | $58,000 | 0.27% |
| AllSquare Wealth Management LLC | 545 | $1,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 17,979 | $17,000 | 0.00% |
| Creative Planning | 10,832 | $10,000 | 0.00% |
| ROYAL BANK OF CANADA | 250 | $0 | 0.00% |
| TCI Wealth Advisors, Inc. | 125 | $0 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 39,700 | $37,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 1,185 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 13,905 | $13,000 | 0.00% |